AppLovin Plunges to Multi-Year Lows as Revenue Miss and Soft Guidance Challenge Axon Growth Narrative

What happened

AppLovin shares tumbled to their lowest level in over a year after the ad-tech firm reported quarterly sales below consensus and issued weaker-than-expected forward guidance. The miss undermines the prior thesis that Axon Ads Manager could sustain rapid monetization-per-install growth, as the shortfall suggests yield expansion is stalling faster than modeled. The company's own 10-K had warned that rapid growth 'may not be indicative' as comparisons tightened, and this quarter appears to bear that out. With the stock now trading well below the $400 attractive entry level from our WAIT note, the bear case of decelerating free cash flow toward $2.8 billion becomes more plausible. Near-term recovery depends on whether management can quickly recover advertiser budgets, but the broken momentum and elevated regulatory overhang leave limited margin for error.

Implication

The revenue miss confirms our bear-case trajectory where net revenue per install decelerates below 20% and FY2026 free cash flow falls toward $2.8 billion, justifying a valuation closer to $330. While buybacks and balance-sheet strength provide a floor, the growth story is now broken until proven otherwise. Investors should sell into any relief rallies and revisit only if Q3 shows a credible reacceleration.

Thesis delta

The WAIT rating is downgraded to SELL as the Q2 revenue miss and weak outlook break the bull case. The Axon monetization engine is showing saturation signs earlier than expected, and the path to $5.2 billion free cash flow is closed. The new base case shifts to the bear scenario, implying fair value around $330, with downside risk if the SEC probe escalates.